BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade biopreservation media for cell and gene therapies, (“BioLife” or the “Company”), today announced that the Company’s fourth quarter and full year 2018 financial results will be released after market close on Thursday, March 14, 2019,
March 4, 2019
· 1 min read